Company intelligence / Profile preview
Panolos Bioscience
Seongnam, Gyeonggi-do, South Koreapanolos.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Phase 1
01
Overview
PB101 has received Phase I IND Approval and is being evaluated for Hepatocellular Carcinoma. The company has presented PB101 ICI combination effect data at AACR in 2022.
- Therapeutic areas
- GastroenterologyOncologyImmunologyRare Diseases
- Modalities
- Multi-specific antibodiesAntibody fusion proteinsBiological products
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Kelun-Biotech (PB203 co-development, 2022)Chime Biologics (strategic cooperation for PB203)Samsung Biologics (CDMO for PB101)Neoimmunetech (joint research for Hyleukin-7-PB101 combination therapy)Scripps Korea (MOU for multi-target pancreatic cancer/solid tumor therapeutics)Teraimune (MOU for atopic/autoimmune skin disease drug co-development)Deargen (MOU for AI-based drug co-development)
Beyond the preview
Go deeper on Panolos Bioscience.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Panolos Bioscience.